Baker Brothers portfolio, Q1 2025

Baker Bros. Advisors · 13F for the quarter ending Mar 31, 2025

For Q1 2025, Baker Bros. Advisors reported $9B across 89 US-listed positions, led by ONC (26.5%), INCY (20.6%) and ACAD (7.9%). Compared with its filing for Q4 2024, Baker Brothers opened 4 new positions, added to 11, reduced 16 and sold out of 10; 58 positions did not change.

The largest purchase was an addition to IMVT ($64.1M); the largest sale, a reduction of ONC ($199.5M).

Reported value
$9B
Positions
89
In the top 10
82%
Filed
May 15
2025

Key facts

13F portfolio value
$9BQ1 2025
Positions
89
Largest holding
ONC 26.5%
New positions
4
Sold out
10
Filed
May 15, 2025

Holdings as of (Q1 2025), filed with the SEC on . Changes are measured against the filing for Dec 31, 2024. Every tracked investor's Q1 2025 13F.

Bought and sold in Q1 2025

Baker Brothers: buys and sells in Q1 2025
StockMoveSharesSizeOf portfolio
Beone Medicines LtdONC▼ Reduced 7.7%−732.83K$199.5M2.21%
Immunovant IncIMVT▲ Added 220%+3.75M$64.1M0.71%
Ionis Pharmaceuticals Incno ticker on file
▼ Sold out—$29.5M0.33%
Insmed IncINSM▲ Added 7.5%+373.76K$28.5M0.32%
Krystal Biotech IncKRYS▼ Sold out−169.93K$26.6M0.29%
Rhythm Pharmaceuticals IncRYTM▼ Reduced 7.9%−479.77K$25.4M0.28%
Immunocore Holdings plcIMCR▲ Added 53%+807.34K$24M0.27%
Vaxcyte IncPCVX▲ Added more than 10×+592K$22.4M0.25%
CRISPR Therapeutics AGCRSP▼ Reduced 50%−653.91K$22.3M0.25%
Akero Therapeutics Incno ticker on file
▼ Reduced 50%−548.37K$22.2M0.25%
Xenon Pharmaceuticals IncXENE▼ Reduced 65%−646.27K$21.7M0.24%
argenx SEARGX▼ Reduced 31%−34.14K$20.2M0.22%
Celcuity IncCELC▲ Added 59%+1.58M$16M0.18%
Verona Pharma Plcno ticker on file
▲ New+223.84K$14.2M0.16%
Alkermes PLCALKS▲ Added 7.2%+301.53K$10M0.11%
Merus N Vno ticker on file
▼ Reduced 50%−226.5K$9.5M0.11%
Neurogene IncNGNE▲ Added 120%+811.75K$9.5M0.11%
Mirum Pharmaceuticals IncMIRM▼ Sold out−190.48K$7.9M0.09%
Arvinas IncARVN▼ Sold out−405.58K$7.8M0.09%
Rocket Pharmaceuticals IncRCKT▲ Added more than 10×+1M$6.7M0.07%
Biomea Fusion IncBMEA▼ Sold out−1.45M$5.6M0.06%
Regulus Therapeutics Incno ticker on file
▲ New+2.69M$4.7M0.05%
Sionna Therapeutics IncSION▲ New+400K$4.2M0.05%
Vir Biotechnology IncVIR▼ Reduced 50%−542K$3.5M0.04%
Candel Therapeutics IncCADL▼ Reduced 18%−544.79K$3.1M0.03%
Arcturus Therapeutics HoldingsARCT▼ Sold out−151.33K$2.6M0.03%
Compass Therapeutics IncCMPX▼ Reduced 65%−1.01M$1.9M0.02%
Tectonic Therapeutic IncTECX▲ New+100K$1.8M0.02%
Mersana Therapeutics Incno ticker on file
▼ Sold out−1.09M$1.6M0.02%
PTC Therapeutics IncPTCT▼ Sold out−20.4K$920.9K0.01%
Sana Biotechnology IncSANA▼ Reduced 15%−350K$588K0.01%
PMV Pharmaceuticals IncPMVP▼ Sold out−322.02K$486.3K0.01%
Century Therapeutics IncIPSC▼ Reduced 70%−555.78K$264.6K0.00%
Sera Prognostics IncSERA▲ Added 1.2%+63.77K$234.7K0.00%
Leap Therapeutics Incno ticker on file
▼ Reduced 65%−767.43K$234.1K0.00%
Foghorn Therapeutics IncFHTX▼ Sold out−45.03K$212.5K0.00%
Cerus CorpCERS▼ Reduced 0.7%−126.25K$175.5K0.00%
Acrivon Therapeutics IncACRV▼ Reduced 57%−30.08K$61.1K0.00%
Incyte CorpINCY▲ Added 0.00%+487$29.5K0.00%
IGM Biosciences Incno ticker on file
▲ Added 0.02%+953$1.1K0.00%
Opthea Limitedno ticker on file
▼ Reduced 4.0%−86.3K$00.00%

Holdings at the quarter's end

Baker Brothers holdings, Q1 2025
#StockSectorShare of portfolioValueSharesReported priceHeldSince Q4 2024
1Beone Medicines LtdONC · SPONSORED ADSHealth Care26.5%$2.4B8.8M$272.174+ qtrs▼ Reduced 7.7%
2Incyte CorpINCYHealth Care20.6%$1.9B30.74M$60.554+ qtrs▲ Added 0.00%
3Acadia Pharmaceuticals IncACAD—7.88%$712.2M42.88M$16.614+ qtrsNo change
4Madrigal Pharmaceuticals IncMDGLHealth Care7.24%$654M1.97M$331.234+ qtrsNo change
5Summit Therapeutics IncSMMTHealth Care5.21%$471.2M24.42M$19.294+ qtrsNo change
6Insmed IncINSMHealth Care4.54%$410.5M5.38M$76.294+ qtrs▲ Added 7.5%
7Rhythm Pharmaceuticals IncRYTMHealth Care3.29%$296.9M5.6M$52.974+ qtrs▼ Reduced 7.9%
8Revolution Medicines IncRVMDHealth Care3.11%$280.7M7.94M$35.364+ qtrsNo change
9Kymera Therapeutics IncKYMRHealth Care1.82%$164.1M6M$27.374+ qtrsNo change
10Alkermes PLCALKS · SHSHealth Care1.64%$148M4.48M$33.024+ qtrs▲ Added 7.2%
11Edgewise Therapeutics IncEWTXHealth Care1.50%$135.4M6.16M$22.004+ qtrsNo change
12Replimune Group IncREPL—1.19%$107.7M11.05M$9.754+ qtrsNo change
13
Insmed Incno ticker on file · NOTE 0.75% 6/1/2028
—1.12%$101.6M——4+ qtrsNo change
14Immunovant IncIMVTHealth Care1.03%$93.3M5.46M$17.094+ qtrs▲ Added 220%
15Bicycle Therapeutics PlcBCYC · SPONSORED ADS—1.02%$92.4M10.89M$8.494+ qtrsNo change
16Immunocore Holdings plcIMCR · ADS—0.76%$68.9M2.32M$29.674+ qtrs▲ Added 53%
17Kiniksa Pharmaceuticals InternationalKNSA · ORD SHS CL AHealth Care0.69%$62.6M2.82M$22.214+ qtrsNo change
18Abcellera Biologics IncABCL—0.68%$61.4M27.53M$2.234+ qtrsNo change
19Ultragenyx PharmaceuticalRARE—0.63%$57.1M1.58M$36.214+ qtrsNo change
20Denali Therapeutics IncDNLI—0.56%$50.7M3.73M$13.604+ qtrsNo change
21Kodiak Sciences IncKODHealth Care0.54%$48.6M17.31M$2.804+ qtrsNo change
22Nurix Therapeutics IncNRIX—0.51%$46.1M3.88M$11.884+ qtrsNo change
23argenx SEARGX · SPONSORED ADRHealth Care0.51%$46M77.76K$591.864+ qtrs▼ Reduced 31%
24Entrada Therapeutics IncTRDA—0.49%$44M4.87M$9.044+ qtrsNo change
25Celcuity IncCELC—0.48%$43M4.26M$10.114+ qtrs▲ Added 59%
26Grail IncGRALHealth Care0.46%$41.6M1.63M$25.542 qtrsNo change
27Roivant Sciences LtdROIV · SHSHealth Care0.42%$38M3.77M$10.094+ qtrsNo change
28Immatics N.V.IMTX · SHS—0.36%$32.8M7.28M$4.514+ qtrsNo change
29Stoke Therapeutics IncSTOK—0.34%$30.8M4.63M$6.654+ qtrsNo change
30Cerus CorpCERS—0.30%$26.9M19.35M$1.394+ qtrs▼ Reduced 0.7%
31Vaxcyte IncPCVXHealth Care0.27%$24.2M640.89K$37.764+ qtrs▲ Added more than 10×
32Monte Rosa Therapeutics IncGLUE—0.25%$22.8M4.92M$4.644+ qtrsNo change
33CRISPR Therapeutics AGCRSP · NAMEN AKTHealth Care0.25%$22.3M654.1K$34.034+ qtrs▼ Reduced 50%
34
Akero Therapeutics Incno ticker on file
—0.25%$22.2M548.71K$40.484+ qtrs▼ Reduced 50%
35Sera Prognostics IncSERA · CLASS A COM—0.22%$20.2M5.5M$3.684+ qtrs▲ Added 1.2%
36
Centessa Pharmaceuticals PLCno ticker on file · SPONSORED ADS
—0.20%$17.6M1.23M$14.384+ qtrsNo change
37Neurogene IncNGNE—0.19%$17.4M1.49M$11.714+ qtrs▲ Added 120%
38IDEAYA Biosciences IncIDYA—0.19%$17.4M1.06M$16.384+ qtrsNo change
39
Verona Pharma Plcno ticker on file · SPONSORED ADS
—0.16%$14.2M223.84K$63.491 qtrNew
40Candel Therapeutics IncCADL—0.15%$13.8M2.44M$5.652 qtrs▼ Reduced 18%
41Praxis Precision MedicinesPRAXHealth Care0.14%$12.6M331.53K$37.874+ qtrsNo change
42
2seventy bio Incno ticker on file
—0.14%$12.3M2.5M$4.944+ qtrsNo change
43Xenon Pharmaceuticals IncXENE—0.13%$11.7M347.41K$33.554+ qtrs▼ Reduced 65%
44Bicara Therapeutics IncBCAX—0.12%$10.9M833.33K$13.033 qtrsNo change
45Ionis Pharmaceuticals IncIONSHealth Care0.12%$10.8M357.92K$30.173 qtrsNo change
46Dbv Technologies S A SponsoredDBVT · SPONSORED ADS—0.11%$10M1.46M$6.824+ qtrsNo change
47Alumis IncALMS—0.11%$9.6M1.56M$6.144+ qtrsNo change
48
Merus N Vno ticker on file
—0.10%$9.4M223.5K$42.094+ qtrs▼ Reduced 50%
49Prelude Therapeutics IncPRLD—0.09%$7.8M10.12M$0.76804+ qtrsNo change
50
Verve Therapeutics Incno ticker on file
—0.09%$7.7M1.69M$4.574+ qtrsNo change
51Rocket Pharmaceuticals IncRCKT—0.08%$7.3M1.1M$6.672 qtrs▲ Added more than 10×
52Xencor IncXNCR—0.08%$7.1M670.43K$10.644+ qtrsNo change
53Dyne Therapeutics IncDYN—0.08%$7M672.1K$10.464+ qtrsNo change
54KALA BIO IncKALA—0.08%$6.9M1.2M$5.734+ qtrsNo change
55Design Therapeutics IncDSGN—0.07%$6.7M1.74M$3.864+ qtrsNo change
56Structure Therapeutics IncGPCR · SPONSORED ADS—0.07%$6.3M361.57K$17.313 qtrsNo change
57Taysha Gene Therapies IncTSHA—0.06%$5.6M4M$1.394+ qtrsNo change
58
Regulus Therapeutics Incno ticker on file
—0.05%$4.7M2.69M$1.751 qtrNew
59
IGM Biosciences Incno ticker on file
—0.05%$4.7M4.1M$1.154+ qtrs▲ Added 0.02%
60Intellia Therapeutics IncNTLA—0.05%$4.6M644.12K$7.112 qtrsNo change
61Celldex Therapeutics IncCLDX—0.05%$4.5M247.64K$18.154+ qtrsNo change
62Sionna Therapeutics IncSION—0.05%$4.2M400K$10.461 qtrNew
63BioNTech SEBNTX · SPONSORED ADSHealth Care0.05%$4.1M45.03K$91.062 qtrsNo change
64TScan Therapeutics IncTCRX—0.04%$3.8M2.78M$1.384+ qtrsNo change
65Disc Medicine IncIRON—0.04%$3.8M77.05K$49.642 qtrsNo change
66Vir Biotechnology IncVIR—0.04%$3.5M542.54K$6.482 qtrs▼ Reduced 50%
67Sana Biotechnology IncSANA—0.04%$3.4M2.03M$1.684+ qtrs▼ Reduced 15%
68Sagimet Biosciences IncSGMT—0.03%$3.1M953K$3.264+ qtrsNo change
69Relay Therapeutics IncRLAY—0.03%$3M1.16M$2.624+ qtrsNo change
70Wave Life Sciences LtdWVE · SHS—0.03%$2.8M344.06K$8.083 qtrsNo change
71Fate Therapeutics IncFATE—0.03%$2.6M3.26M$0.79014+ qtrsNo change
72Skye Bioscience IncSKYE—0.03%$2.3M1.45M$1.594+ qtrsNo change
73Protara Therapeutics IncTARA—0.03%$2.3M536.83K$4.264+ qtrsNo change
74Enliven Therapeutics IncELVN—0.03%$2.3M114.83K$19.684+ qtrsNo change
75Contineum Therapeutics IncCTNM · CL A—0.02%$2.2M312.5K$6.984+ qtrsNo change
76Prime Medicine IncPRME—0.02%$2M1.03M$1.994+ qtrsNo change
77Tectonic Therapeutic IncTECX—0.02%$1.8M100K$17.711 qtrNew
78vTv Therapeutics IncVTVT · CL A—0.02%$1.7M97.31K$17.324+ qtrsNo change
79Compass Therapeutics IncCMPX—0.01%$1M547.5K$1.904+ qtrs▼ Reduced 65%
80Neumora Therapeutics IncNMRA—0.01%$1M1.03M$1.004+ qtrsNo change
81
HOOKIPA Pharma Incno ticker on file
—0.01%$877.8K812.81K$1.084+ qtrsNo change
82
Generation Bio Cono ticker on file
—0.01%$787.7K1.94M$0.40504+ qtrsNo change
83Aligos Therapeutics IncALGS—0.01%$685.2K83.06K$8.254+ qtrsNo change
84
Leap Therapeutics Incno ticker on file
—0.00%$123.5K404.74K$0.30514+ qtrs▼ Reduced 65%
85Century Therapeutics IncIPSC—0.00%$115K241.68K$0.47604+ qtrs▼ Reduced 70%
86Tyra Biosciences IncTYRA—0.00%$98.6K10.61K$9.304+ qtrsNo change
87Acrivon Therapeutics IncACRV—0.00%$46.3K22.81K$2.034+ qtrs▼ Reduced 57%
88
Surrozen Incno ticker on file · W EXP 8/11/2026
—0.00%$25K833.33K$0.03004+ qtrsNo change
89
Opthea Limitedno ticker on file · SPONSORED ADS
—0.00%$02.09M—4+ qtrs▼ Reduced 4.0%

By sector

Baker Brothers portfolio by sector, Q1 2025
SectorShare of portfolioValuePositions
Health Care79.9%$7.2B21
No sector on file20.1%$1.8B68

Questions and answers

What did Baker Brothers own in Q1 2025?

Baker Bros. Advisors's 13F for Q1 2025 lists 89 positions worth $9B. The largest: ONC (26.5%), INCY (20.6%), ACAD (7.9%), MDGL (7.2%), SMMT (5.2%).

What did Baker Brothers buy in Q1 2025?

The largest purchases, by the shares bought at the quarter-end price the filing implies: IMVT (added, $64.1M), INSM (added, $28.5M), IMCR (added, $24M), PCVX (added, $22.4M), CELC (added, $16M), Verona Pharma Plc (new, $14.2M).

What did Baker Brothers sell in Q1 2025?

The largest sales: ONC (reduced, $199.5M), Ionis Pharmaceuticals Inc (sold out, $29.5M), KRYS (sold out, $26.6M), RYTM (reduced, $25.4M), CRSP (reduced, $22.3M), Akero Therapeutics Inc (reduced, $22.2M).

When was this filing made?

Baker Bros. Advisors filed its 13F for the quarter ending Mar 31, 2025 on May 15, 2025. A 13F is due within 45 days of the quarter's end, so the positions were already weeks old when it became public.

Learn

Cite this page

Funkfolio, “Baker Brothers portfolio, Q1 2025: Baker Bros. Advisors 13F holdings”, data as of 15 May 2025. https://funkfolio.com/gurus/baker-brothers/2025-q1

Underlying data: SEC EDGAR, Form 13F-HR of Baker Bros. Advisors (CIK 1263508) for the period ending Mar 31, 2025.

Source: SEC EDGAR, Form 13F-HR for Baker Bros. Advisors (CIK 1263508), period ending Mar 31, 2025, filed May 15, 2025. Changes compare share counts with the filing for Dec 31, 2024; a share split in between is allowed for where one is on record. “Reported price” is a position's reported value divided by its shares. The size of a buy or sell is the change in shares at that price; a position sold out is sized at its value in the previous filing, and “of portfolio” sets the size against the $9B reported for this quarter. “Held” counts consecutive quarterly filings up to this one, out of the 4 looked at from here back. Sectors are those of the ranked companies on this site as they stand today. Not a live portfolio and not advice.